The oncology analytics software developer received a top-up from investors including NEC Corporation at a unicorn valuation.

Pfizer Ventures was among the investors in Triana’s series A round and has taken a board seat at the molecular glue platform developer.

The Takeda spinoff is developing a vaccine for acute gastroenteritis caused by norovirus infection, and raised about $140m in August 2021.

Wipro and Intel backed customer experience platform developer Lilt's $55m series C while Pfizer is buying corporate-backed respiratory virus therapeutic developer ReViral for up to $525m.

Kraken, OK Group, 9fBank and Baofoo are in line to exit Wyre, with its cryptocurrency infrastructure technology to strengthen Bolt's one-click checkout offering.

The cryptocurrency exchange’s US spinoff pulled in a nine-figure sum from investors like Circle Ventures at a post-money valuation of $4.7bn.

SoftBank, TelevisaUnivision and NielsenIQ helped provide the customer loyalty app developer with fresh capital in a round more than doubling its valuation to $2.5bn.

China Life Private Equity Investment and PICC Capital returned to co-lead the pharmaceutical discovery technology provider’s latest rounds, four months after it emerged from stealth.

Mitsui took part in oncology therapy developer Ensem Therapeutics' $67m series A round while Bioventus is paying up to $450m to buy the rest of portfolio company CartiHeal.

The sports gear retailer has disclosed its largest round was led by the NFL and included the MLB, NHL and Paris Saint-Germain, at a $27bn valuation.